Mirae Asset Global Investments
INO icon

Mirae Asset Global Investments’s Inovio Pharmaceuticals INO Stock Holding History

Mirae Asset Global Investments’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,703
Closed -$75.8K – 2650
2023
Q1 		$75.8K Buy
+7,703
New +$131K ﹤0.01% 2482
2022
Q2 		– Sell
-2,395
Closed -$103K – 2421
2022
Q1 		$103K Buy
2,395
+1,155
+93% +$52K ﹤0.01% 1562
2021
Q4 		$75K Buy
+1,240
New +$99.3K ﹤0.01% 1555

Other funds holding INO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Mirae Asset Global Investments's INO Position: Q2 2023 in Review

Mirae Asset Global Investments sold out of Inovio Pharmaceuticals (INO) in Q2 2023, closing a stake of 7,703 shares — an estimated $75.8K sold.

Mirae Asset Global Investments first reported a position in INO in Q4 2021 and held it in 3 quarters. The position peaked at $103K in Q1 2022. 133 funds tracked by Wall St. Rank hold INO as of Q2 2023.

  • Mirae Asset Global Investments reported no remaining Inovio Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Mirae Asset Global Investments sold 7,703 Inovio Pharmaceuticals shares in Q2 2023, an estimated $75.8K.
  • Mirae Asset Global Investments first reported a position in Inovio Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • Mirae Asset Global Investments's Inovio Pharmaceuticals position peaked at $103K in Q1 2022.
  • 133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2023.

Based on Mirae Asset Global Investments's 13F filing for Q2 2023, filed 10 Aug 2023.